Biden’s Proposed Budget Boosts Investment in Clean Energy Technologies

Mintz continues its ongoing commitment to ensuring the firm is an equitable workplace, establishing a new Diversity, Equity and Inclusion (DEI) committee that reports directly to the firm's main decision making body, the Policy Committee. The new Equity Advisory Council (EAC) will be responsible for driving equity for the firm’s attorneys, especially women, attorneys of color and LGBTQ+ attorneys.

Mintz took lead role for long-term client NanoView Biosciences in its sale to Unchained Labs, a portfolio company of The Carlyle Group. NanoView, through its ExoView technology, characterizes exosomes and the company’s LentiView platform complements Unchained Labs’ tools for gene therapy researchers working with lentivirus, which is an immunodeficiency virus that causes AIDS.

Mintz Member Suman Chakraborty tells his journey of becoming a recognized first-chair litigator as an LGBTQ+ attorney of color in an article published by the New York Law Journal. 

Mintz's consecutive revenue growth and firm successes for the fiscal 2021 year were recognized in an article published by The American Lawyer. Mintz Managing Member Bob Bodian outlined in the article the growth in revenue, the addition of new Members, and important policies that Mintz put into place this year for its employees. 

A team of two new Members and an Of Counsel with deep patenting capabilities and decades of experience supporting biotech and pharmaceutical clients enhances our already robust Life Sciences IP prosecution and strategy practice.